Form 8-K Medtronic plc For: May 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities
May 27, 2022 8:09 AM EDTTruist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.
The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More
Medtronic, Inc. (MDT) PT Lowered to $117 at Cowen; FY23 Can Be a Year of Real Pipeline Progress
May 27, 2022 6:21 AM EDTCowen analyst Joshua Jennings lowered the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $125.00) while maintaining an Outperform rating following earnings. Despite weak guidance, the analyst said FY23 can be a year of real pipeline progress.
The analyst commented, "MDT delivered... More
Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel
May 27, 2022 6:13 AM EDTStifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $125.00 (from $128.00) while maintaining a Buy rating.
The analyst commented, "Yes. We had hoped that Medtronics F4Q22 (Apr.) would show more visibly-positive signs of CEO Geoff Marthas positive... More
